Cargando…
Influenza Vaccination Coverage among Multiple Sclerosis Patients: Evolution over Time and Associated Factors
Our objective was to determine the influenza vaccination rate in a Spanish cohort of multiple sclerosis (MS) patients. A retrospective cohort study was carried out. Patients who attended the MS unit of the Lozano Blesa Hospital of Zaragoza between January 2015 and 2020 were included. The variables w...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322179/ https://www.ncbi.nlm.nih.gov/pubmed/35891321 http://dx.doi.org/10.3390/vaccines10071154 |
_version_ | 1784756234393485312 |
---|---|
author | Hernández-García, Ignacio Garcés-Redondo, Moisés Rodríguez-Montolio, Joana Bengoa-Urrengoechea, Irantzu Espinosa-Rueda, Judit Aibar-Remón, Carlos |
author_facet | Hernández-García, Ignacio Garcés-Redondo, Moisés Rodríguez-Montolio, Joana Bengoa-Urrengoechea, Irantzu Espinosa-Rueda, Judit Aibar-Remón, Carlos |
author_sort | Hernández-García, Ignacio |
collection | PubMed |
description | Our objective was to determine the influenza vaccination rate in a Spanish cohort of multiple sclerosis (MS) patients. A retrospective cohort study was carried out. Patients who attended the MS unit of the Lozano Blesa Hospital of Zaragoza between January 2015 and 2020 were included. The variables were obtained by reviewing the specialized and primary care records. Associations between receiving the vaccine in each flu season and the other variables were analyzed using bivariate analysis and multiple logistic regression models. A total of 260 patients were studied, with a median age of 31 years at the time of diagnosis. A total of 62.3% (162/260) were women. Vaccination coverage ranged from 20.4% in the 2015–2016 and 2016–2017 seasons to 41.5% in the 2019–2020 season (p = 0.000). Having been vaccinated in the previous season (ORa: 16.47–390.22; p = 0.000) and receiving a vaccination recommendation from the hospital vaccination unit (ORa: 2.44–3.96; p < 0.009) were associated with being vaccinated. The coverage is in an intermediate position compared to other countries. It is necessary to improve the referral system of these patients to the hospital vaccination unit because the information obtained by this service contributed to higher vaccination rates. |
format | Online Article Text |
id | pubmed-9322179 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93221792022-07-27 Influenza Vaccination Coverage among Multiple Sclerosis Patients: Evolution over Time and Associated Factors Hernández-García, Ignacio Garcés-Redondo, Moisés Rodríguez-Montolio, Joana Bengoa-Urrengoechea, Irantzu Espinosa-Rueda, Judit Aibar-Remón, Carlos Vaccines (Basel) Article Our objective was to determine the influenza vaccination rate in a Spanish cohort of multiple sclerosis (MS) patients. A retrospective cohort study was carried out. Patients who attended the MS unit of the Lozano Blesa Hospital of Zaragoza between January 2015 and 2020 were included. The variables were obtained by reviewing the specialized and primary care records. Associations between receiving the vaccine in each flu season and the other variables were analyzed using bivariate analysis and multiple logistic regression models. A total of 260 patients were studied, with a median age of 31 years at the time of diagnosis. A total of 62.3% (162/260) were women. Vaccination coverage ranged from 20.4% in the 2015–2016 and 2016–2017 seasons to 41.5% in the 2019–2020 season (p = 0.000). Having been vaccinated in the previous season (ORa: 16.47–390.22; p = 0.000) and receiving a vaccination recommendation from the hospital vaccination unit (ORa: 2.44–3.96; p < 0.009) were associated with being vaccinated. The coverage is in an intermediate position compared to other countries. It is necessary to improve the referral system of these patients to the hospital vaccination unit because the information obtained by this service contributed to higher vaccination rates. MDPI 2022-07-21 /pmc/articles/PMC9322179/ /pubmed/35891321 http://dx.doi.org/10.3390/vaccines10071154 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Hernández-García, Ignacio Garcés-Redondo, Moisés Rodríguez-Montolio, Joana Bengoa-Urrengoechea, Irantzu Espinosa-Rueda, Judit Aibar-Remón, Carlos Influenza Vaccination Coverage among Multiple Sclerosis Patients: Evolution over Time and Associated Factors |
title | Influenza Vaccination Coverage among Multiple Sclerosis Patients: Evolution over Time and Associated Factors |
title_full | Influenza Vaccination Coverage among Multiple Sclerosis Patients: Evolution over Time and Associated Factors |
title_fullStr | Influenza Vaccination Coverage among Multiple Sclerosis Patients: Evolution over Time and Associated Factors |
title_full_unstemmed | Influenza Vaccination Coverage among Multiple Sclerosis Patients: Evolution over Time and Associated Factors |
title_short | Influenza Vaccination Coverage among Multiple Sclerosis Patients: Evolution over Time and Associated Factors |
title_sort | influenza vaccination coverage among multiple sclerosis patients: evolution over time and associated factors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322179/ https://www.ncbi.nlm.nih.gov/pubmed/35891321 http://dx.doi.org/10.3390/vaccines10071154 |
work_keys_str_mv | AT hernandezgarciaignacio influenzavaccinationcoverageamongmultiplesclerosispatientsevolutionovertimeandassociatedfactors AT garcesredondomoises influenzavaccinationcoverageamongmultiplesclerosispatientsevolutionovertimeandassociatedfactors AT rodriguezmontoliojoana influenzavaccinationcoverageamongmultiplesclerosispatientsevolutionovertimeandassociatedfactors AT bengoaurrengoecheairantzu influenzavaccinationcoverageamongmultiplesclerosispatientsevolutionovertimeandassociatedfactors AT espinosaruedajudit influenzavaccinationcoverageamongmultiplesclerosispatientsevolutionovertimeandassociatedfactors AT aibarremoncarlos influenzavaccinationcoverageamongmultiplesclerosispatientsevolutionovertimeandassociatedfactors AT influenzavaccinationcoverageamongmultiplesclerosispatientsevolutionovertimeandassociatedfactors |